Cipla shares are in demand on Dalal Street amid market buzz that it is in talks with Eli Lilly for the Semaglutide drug. Catch the latest market updates here. Cipla shares buzzed in trade on Monday.

Cipla Ltd’s promoters are in advanced talks with two consortiums—one led by Torrent Pharmaceuticals Ltd, with the participation of prominent family offices, and the other a group of buyout firms led ...

SHANGHAI, July 2 (Reuters) - Indian drugmaker Cipla (CIPL.NS), opens new tab is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to work ...

India's fourth-largest drugmaker Cipla plans to increase focus on private market segment across core geographies and review participation in low margin tenders, besides addressing issues of supply ...

Cipla Ltd hopes to transform itself into a global healthcare organisation with a sharp focus on strengthening its presence in the US market, along with doubling its Indian business, said pharma ...

The firm released a digital video with celebs from different walks of life talking about inhaler therapy. Global pharmaceutical company Cipla, recently launched a TVC #InhalersHainSahi, as part of its ...

He may be an NRI who spends half the year abroad, but Cipla's Chairman Yusuf Khwaja Hamied, 74, tracks developments in India and in his company every minute, while also keeping himself abreast of ...

Cipla Share Price Today Highlights, 14 Nov, 2024: Cipla share were in the news and the counter closed trade on 13 Nov, 2024 at Rs 1507.1. The shares touched intraday high of Rs 1525.0 in the last ...

Cipla, which saw its market valuation rising about 56% in the last six years, posted a 126% growth in sales over the period to `8,524 crore in March 2013 and has set a target of $5 billion sales by ...